English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Trytosaveabit commented on a stock · Oct 23, 2023 17:00

News

$Roivant Sciences (ROIV.US)$ The Swiss pharmaceutical giant said Monday that it will pay $7.1 billion upfront and make a near-term milestone payment of $150 million to gain rights in the US and Japan to develop and market the drug known as RVT-3101.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
22K Views
Comment
Sign in to post a comment
    avatar
    Trytosaveabit
    4915
    Followers
    24
    Following
    70K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    TSLA
    Tesla
    -- 355.840
    NVDA
    NVIDIA
    -- 138.850
    INTC
    Intel
    -- 23.600
    NBIS
    NEBIUS
    -- 44.490
    PLTR
    Palantir
    -- 119.160
    Discussing
    Trump 2.0 Era: How will global markets evolve?
    🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
    MicroStrategy Q4 2024 earnings conference call
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.